BCG Tokyo-172 strain vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011895
A vaccine containing bacillus Calmette-Guerin (BCG), a live, attenuated strain of Mycobacterium bovis obtained from the Pasteur Institute in 1924, with non-specific immunoadjuvant and immunotherapeutic activities. Upon intradermal administration, BCG Tokyo-172 strain vaccine activates the immune system and enhances a specific, systemic BCG antigen immune response. This results in active immunization against tuberculosis and primes the immune system against future administered BCG antigens.
| Identifier | MLC-T-ONC-011895 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | bacillus Calmette-Guerin Tokyo-172 strain vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011895",
"term": "BCG Tokyo-172 strain vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine containing bacillus Calmette-Guerin (BCG), a live, attenuated strain of Mycobacterium bovis obtained from the Pasteur Institute in 1924, with non-specific immunoadjuvant and immunotherapeutic activities. Upon intradermal administration, BCG Tokyo-172 strain vaccine activates the immune system and enhances a specific, systemic BCG antigen immune response. This results in active immunization against tuberculosis and primes the immune system against future administered BCG antigens.",
"synonyms": [
"bacillus Calmette-Guerin Tokyo-172 strain vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bcg-tokyo-172-strain-vaccine/"
}
Record 3,336 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.